XML 50 R33.htm IDEA: XBRL DOCUMENT v3.22.4
Revenues and Accounts Receivable (Tables)
12 Months Ended
Dec. 31, 2022
Revenues And Accounts Receivable [Abstract]  
Schedule of Contract Balances

The following table presents the Company’s contract balances as of December 31:

 

 

2022

 

 

2021

 

Contract assets

$

52,403

 

 

$

40,139

 

Contract liabilities (Note 10)

 

18,549

 

 

 

27,907

 

Schedule of Accounts Receivable, Net

Accounts Receivable, Net—Accounts receivable, net as of December 31, consisted of the following:

 

 

 

2022

 

 

2021

 

Accounts receivable, invoiced

 

$

95,055

 

 

$

101,709

 

Accounts receivable, other

 

 

1,571

 

 

 

1,385

 

Allowance for doubtful accounts

 

 

(1,915

)

 

 

(4,581

)

Accounts receivable—net

 

$

94,711

 

 

$

98,513

 

Schedule of Allowance for Doubtful Accounts

The allowance for doubtful accounts consisted of the following:

 

 

 

Beginning
Balance

 

 

Bad Debt
(Recovery)
Expense

 

 

Charged to
Allowance

 

 

Other(1)

 

 

Ending
Balance

 

Year ended December 31, 2022

 

$

4,581

 

 

$

(1,097

)

 

$

(1,696

)

 

$

127

 

 

$

1,915

 

Year ended December 31, 2021

 

 

4,265

 

 

 

1,135

 

 

 

(1,548

)

 

 

729

 

 

 

4,581

 

Year ended December 31, 2020 (2)

 

 

1,327

 

 

 

4,532

 

 

 

(2,633

)

 

 

1,039

 

 

$

4,265

 

 

(1)
This amount consists of additions to the allowance due to business acquisitions.
(2)
During the first quarter of 2020, there was a global outbreak of a new strain of coronavirus, COVID-19. The COVID-19 pandemic added uncertainty to the collectability of certain receivables, particularly in industries hard hit by the pandemic. As a result, the Company recorded $6.3 million of bad debt reserve during the first quarter of 2020. The bad debt adjustment included a $5.5 million reserve for one customer in the Company’s Remediation and Reuse segment in which management concluded to discontinue select service lines as of June 30, 2020 (Note 21).